18-3154984-C-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_003803.4(MYOM1):c.1606G>A(p.Asp536Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000725 in 1,612,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D536Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_003803.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYOM1 | ENST00000356443.9 | c.1606G>A | p.Asp536Asn | missense_variant | Exon 11 of 38 | 1 | NM_003803.4 | ENSP00000348821.4 | ||
| MYOM1 | ENST00000261606.11 | c.1606G>A | p.Asp536Asn | missense_variant | Exon 11 of 37 | 1 | ENSP00000261606.7 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152202Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000125 AC: 31AN: 247054 AF XY: 0.000119 show subpopulations
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460520Hom.: 0 Cov.: 30 AF XY: 0.0000716 AC XY: 52AN XY: 726380 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.D536N variant (also known as c.1606G>A), located in coding exon 10 of the MYOM1 gene, results from a G to A substitution at nucleotide position 1606. The aspartic acid at codon 536 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at